INCY Competitors & Alternatives
Compare Incyte Corporation with similar stocks in the same industry
Biotechnology
INCY
Main Stock$97.63
Tradestie Score
65
Market Cap
$16.93B
P/E Ratio
14.0
Revenue Growth
0.2%
Analyst Upside
+11.1%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BNTX
BioNTech SE American Depositary Share
|
$91.99
|
$24.57B | - | 52 | Compare |
|
GMAB
Genmab A/S ADS
|
$26.90
|
$19.56B | 20.3 | 51 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$53.40
|
$15.70B | 28.0 | 64 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$18.14
|
$15.22B | - | 50 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$245.49
|
$12.36B | 27.2 | 59 | Compare |
|
EXEL
Exelixis Inc
|
$51.10
|
$11.09B | 16.3 | 61 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$29.50
|
$10.76B | - | 64 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$50.03
|
$10.74B | - | 58 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$53.24
|
$10.53B | 38.5 | 63 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$75.68
|
$10.49B | - | 66 | Compare |
More INCY Analysis
Data updated: May 15, 2026 | Industry: Biotechnology (SIC 8731)
230 stocks in this industry